Pharmacists in Dallas, Oregon


12 Pharmacists found in Dallas
male pharmacist

David Mooso, PHARM D


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
321 Nw Kings Valley Highway, Dallas, OR 97338
503-420-2439    

male pharmacist

David C Zandberg, R.PH.


Pharmacist
138 W Ellendale Ave, Dallas, OR 97338
503-831-6006     503-831-6008

female pharmacist

Dena Michelle Hollman


Pharmacist
178 W Ellendale Ave, Dallas, OR 97338
503-623-8334    



male pharmacist

John Mark Kangas


Pharmacist
138 W Ellendale Ave, Dallas, OR 97338
503-831-6006     503-831-6008

male pharmacist

Dr. Joseph Edward King Iv, PHARM-D


Pharmacist
625 Se Miller Ave, Dallas, OR 97338
503-623-2400     503-623-5799

female pharmacist

Mrs. Kristine Harmon


Pharmacist
525 Se Washington St, Dallas, OR 97338
503-623-7306     503-831-3479

female pharmacist

Nancy Luann Yancey, R.PH.


Pharmacist
625 Se Miller Ave, Dallas, OR 97338
503-623-2400     503-623-5799

female pharmacist

Petra Alice Runckel, PHARMD


Pharmacist
525 Se Washington St, Dallas, OR 97338
503-623-7306    

female pharmacist

Dr. Sarah K Brattain, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
138 W Ellendale Ave, Dallas, OR 97338
503-831-6006    

male pharmacist

Sergiu Todor


Pharmacist
525 Se Washington St, Dallas, OR 97338
503-623-8301    

female pharmacist

Susan Zofchak, RPH


Pharmacist
178 W Ellendale Ave, Dallas, OR 97338
503-623-8334     503-623-7077

female pharmacist

Tiffany K Duell, RPH



525 Se Washington St, Dallas, OR 97338
503-917-2013     503-917-2033


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.